Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 300

1.

Povidone-iodine results in rapid killing of thymic epithelial tumour cells through cellular fixation.

Lee HS, Jang HJ, Lo EM, Truong CY, Groth SS, Friedberg JS, Sugarbaker DJ, Burt BM.

Interact Cardiovasc Thorac Surg. 2018 Aug 27. doi: 10.1093/icvts/ivy248. [Epub ahead of print]

PMID:
30165653
2.

A Phase I Trial of Surgical Resection and Intraoperative Hyperthermic Cisplatin and Gemcitabine for Pleural Mesothelioma.

Burt BM, Richards WG, Lee HS, Bartel S, Dasilva MC, Gill RR, Jaklitsch MT, Johnson BE, Swanson SJ, Bueno R, Sugarbaker DJ.

J Thorac Oncol. 2018 Sep;13(9):1400-1409. doi: 10.1016/j.jtho.2018.04.032. Epub 2018 May 9.

PMID:
29753120
3.

Comprehensive immunoproteogenomic analyses of malignant pleural mesothelioma.

Lee HS, Jang HJ, Choi JM, Zhang J, de Rosen VL, Wheeler TM, Lee JS, Tu T, Jindra PT, Kerman RH, Jung SY, Kheradmand F, Sugarbaker DJ, Burt BM.

JCI Insight. 2018 Apr 5;3(7). pii: 98575. doi: 10.1172/jci.insight.98575. [Epub ahead of print]

4.

Therapeutic R2 resection for pleural mesothelioma.

Nguyen D, Sugarbaker DJ, Burt BM.

J Thorac Cardiovasc Surg. 2018 Jun;155(6):2734-2735. doi: 10.1016/j.jtcvs.2018.01.025. Epub 2018 Feb 1. No abstract available.

PMID:
29477257
5.

Matrix metalloproteinase 12 promotes tumor propagation in the lung.

Ella E, Harel Y, Abraham M, Wald H, Benny O, Karsch-Bluman A, Vincent D, Laurent D, Amir G, Izhar U, Shapira OM, Yoon D, Lee HS, Sugarbaker DJ, Burt B, Peled A, Wald O.

J Thorac Cardiovasc Surg. 2018 May;155(5):2164-2175.e1. doi: 10.1016/j.jtcvs.2017.11.110. Epub 2018 Feb 21.

PMID:
29429629
6.

Postoperative Chylothorax After Thoracoabdominal Aortic Aneurysm Repair.

Wu D, Chesnokova AE, Akvan S, Price MD, Sugarbaker DJ, Coselli JS, LeMaire SA.

Semin Thorac Cardiovasc Surg. 2018 Summer;30(2):215-219. doi: 10.1053/j.semtcvs.2018.02.005. Epub 2018 Feb 8.

PMID:
29428620
7.

New Concepts in the Treatment of Malignant Pleural Mesothelioma.

Wald O, Sugarbaker DJ.

Annu Rev Med. 2018 Jan 29;69:365-377. doi: 10.1146/annurev-med-041316-085813. Epub 2017 Oct 13.

PMID:
29029582
8.

Soluble Mesothelin-Related Peptides to Monitor Recurrence After Resection of Pleural Mesothelioma.

Burt BM, Lee HS, Lenge De Rosen V, Hamaji M, Groth SS, Wheeler TM, Sugarbaker DJ.

Ann Thorac Surg. 2017 Nov;104(5):1679-1687. doi: 10.1016/j.athoracsur.2017.06.042. Epub 2017 Sep 28.

PMID:
28964420
9.

Intraoperative adjuncts for malignant pleural mesothelioma.

Chan WH, Sugarbaker DJ, Burt BM.

Transl Lung Cancer Res. 2017 Jun;6(3):285-294. doi: 10.21037/tlcr.2017.05.04. Review.

10.

Malignant pleural mesothelioma: key determinants in tailoring the right treatment for the right patient.

Wald O, Sugarbaker DJ.

J Thorac Dis. 2017 Mar;9(3):485-489. doi: 10.21037/jtd.2017.03.27. No abstract available.

11.

Alternative conduits for esophageal replacement.

Bakshi A, Sugarbaker DJ, Burt BM.

Ann Cardiothorac Surg. 2017 Mar;6(2):137-143. doi: 10.21037/acs.2017.03.07.

12.

Genomic Analysis of Thymic Epithelial Tumors Identifies Novel Subtypes Associated with Distinct Clinical Features.

Lee HS, Jang HJ, Shah R, Yoon D, Hamaji M, Wald O, Lee JS, Sugarbaker DJ, Burt BM.

Clin Cancer Res. 2017 Aug 15;23(16):4855-4864. doi: 10.1158/1078-0432.CCR-17-0066. Epub 2017 Apr 11.

13.

The seven attributes of the academic surgeon: Critical aspects of the archetype and contributions to the surgical community.

Rosengart TK, Mason MC, LeMaire SA, Brandt ML, Coselli JS, Curley SA, Mattox KL, Mills JL, Sugarbaker DJ, Berger DA.

Am J Surg. 2017 Aug;214(2):165-179. doi: 10.1016/j.amjsurg.2017.02.003. Epub 2017 Feb 20.

14.

Integrated genomic analysis of recurrence-associated small non-coding RNAs in oesophageal cancer.

Jang HJ, Lee HS, Burt BM, Lee GK, Yoon KA, Park YY, Sohn BH, Kim SB, Kim MS, Lee JM, Joo J, Kim SC, Yun JS, Na KJ, Choi YL, Park JL, Kim SY, Lee YS, Han L, Liang H, Mak D, Burks JK, Zo JI, Sugarbaker DJ, Shim YM, Lee JS.

Gut. 2017 Feb;66(2):215-225. doi: 10.1136/gutjnl-2015-311238. Epub 2016 Aug 9.

15.

Utility of Adjuvant Chemotherapy After Neoadjuvant Chemoradiation and Esophagectomy for Esophageal Cancer.

Burt BM, Groth SS, Sada YH, Farjah F, Cornwell L, Sugarbaker DJ, Massarweh NN.

Ann Surg. 2017 Aug;266(2):297-304. doi: 10.1097/SLA.0000000000001954.

PMID:
27501170
16.

Progression of EGFR-Mutant Lung Adenocarcinoma is Driven By Alveolar Macrophages.

Wang DH, Lee HS, Yoon D, Berry G, Wheeler TM, Sugarbaker DJ, Kheradmand F, Engleman E, Burt BM.

Clin Cancer Res. 2017 Feb 1;23(3):778-788. doi: 10.1158/1078-0432.CCR-15-2597. Epub 2016 Aug 5.

17.

Role of thoracoscopy, mediastinoscopy and laparoscopy in the diagnosis and staging of malignant pleural mesothelioma.

Wald O, Groth SS, Burt BM, Sugarbaker DJ.

J Vis Surg. 2016 Aug 2;2:129. doi: 10.21037/jovs.2016.07.12. eCollection 2016. Review.

18.

Pneumonectomy for Non-Small Cell Lung Cancer.

Sugarbaker DJ, Haywood-Watson RJ, Wald O.

Surg Oncol Clin N Am. 2016 Jul;25(3):533-51. doi: 10.1016/j.soc.2016.02.012. Review.

PMID:
27261914
19.

Perioperative Ischemic Optic Neuropathy Following Extrapleural Pneumonectomy.

Ng JM, Sugarbaker DJ, Bienfang DC, Richards WG, DaSilva MC, Frendl G, Hartigan PM.

J Cardiothorac Vasc Anesth. 2016 Dec;30(6):1645-1648. doi: 10.1053/j.jvca.2016.01.002. Epub 2016 Jan 7. No abstract available.

PMID:
27178100
20.

Perspective on malignant pleural mesothelioma diagnosis and treatment.

Wald O, Sugarbaker DJ.

Ann Transl Med. 2016 Mar;4(6):120. doi: 10.21037/atm.2016.03.17. No abstract available.

Supplemental Content

Loading ...
Support Center